日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma.

新型 DNA 交联剂 KL-50 对替莫唑胺治疗后新发和复发性错配修复缺陷型胶质母细胞瘤的患者来源模型具有活性

McCord Matthew, Sears Thomas, Wang Wenxia, Chaliparambil Rahul, An Shejuan, Sarkaria Jann, James C David, Ruggeri Bruce, Gueble Susan, Bindra Ranjit, Horbinski Craig

Methylation profiling of plasma cell-free DNA in pediatric brain tumor patients

儿童脑肿瘤患者血浆游离DNA甲基化谱分析

An, Shejuan; McCortney, Kathleen; Walshon, Jordain; Leonard, Kaethe; Wray, Brian; McCord, Matthew; DeCuypere, Michael; Horbinski, Craig

miR-23a binds to p53 and enhances its association with miR-128 promoter

miR-23a 与 p53 结合并增强其与 miR-128 启动子的结合。

Li, Jincheng; Aung, Lynn Htet Htet; Long, Bo; Qin, Danian; An, Shejuan; Li, Peifeng

MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma

在视网膜母细胞瘤中,microRNA-21通过靶向PDCD4下调Rb1表达

Shen, Fengmei; Mo, Meng-Hsuan; Chen, Liang; An, Shejuan; Tan, Xiaohui; Fu, Yebo; Rezaei, Katayoon; Wang, Zuoren; Zhang, Lin; Fu, Sidney W

[High resolution melting analysis for detecting p53 gene mutations in patients with non-small cell lung cancer]

[高分辨率熔解曲线分析法检测非小细胞肺癌患者p53基因突变]

Chen, Zhihong; An, Shejuan; Xie, Zhi; Yan, Honghong; Chen, Jianguang; Su, Jian; Zhang, Xuchao; Niu, Feiyu; Guo, Weibang; Wu, Yilong

Fusion of EML4 and ALK is associated with development of lung adenocarcinomas lacking EGFR and KRAS mutations and is correlated with ALK expression

EML4和ALK的融合与缺乏EGFR和KRAS突变的肺腺癌的发生发展相关,并且与ALK表达呈正相关。

Zhang, Xuchao; Zhang, Shirley; Yang, Xuening; Yang, Jinji; Zhou, Qing; Yin, Lucy; An, Shejuan; Lin, Jiaying; Chen, Shiliang; Xie, Zhi; Zhu, Mike; Zhang, Xiaolin; Wu, Yi-long